Oral Paxlovid (nirmatrelvir-ritonavir) is highly effective at preventing hospitalization and death from COVID-19, yet it has been remarkably underused, even by patients at highest risk from COVID-19, ...
Health Affairs' Editor-in-Chief Alan Weil interviews Melissa Aldridge of Icahn School of Medicine at Mount Sinai and James J. Peters Bronx Veterans Affairs Medical Center about her recent paper ...